Status:
UNKNOWN
I2S-Health Prevention
Lead Sponsor:
Institut de Cancérologie de la Loire
Collaborating Sponsors:
National Cancer Institute, France
Conditions:
Secondary School Student in General High School Who Does Not Have a Disability That Does Not Allow a Good Understanding of the Study Requirements
Eligibility:
All Genders
15-19 years
Phase:
NA
Brief Summary
Alcohol is the psychoactive substance most experienced by young people. It benefits from positive representations that are reinforced by marketing strategies where advertisers integrate their products...
Detailed Description
Alcohol is recognized as responsible for 50,000 premature deaths per year and as the second most preventable cause of death in France. In adolescence, the brain is in a period of maturation. Many syna...
Eligibility Criteria
Inclusion
- be enrolled in second grade in one of the high schools included
- Have been informed of the study and have not objected to participating
- To be in a general secondary school of general education, of public status
- To be in a high school located in the Auvergne-Rhône Alpes region.
Exclusion
- Having a disability that does not allow a good understanding of the study requirements
- Student who opposed participation in the study
- High school without a general education section
- High school included in another research protocol
Key Trial Info
Start Date :
February 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 29 2019
Estimated Enrollment :
486 Patients enrolled
Trial Details
Trial ID
NCT03759626
Start Date
February 6 2019
End Date
June 29 2019
Last Update
February 11 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Americain University of Washington
Washington, Massachusetts, United States, 20016
2
Mutualité Française de la Loire
Saint-Etienne, France, 42100
3
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, France, 42270